115152 ⎘
Acyltransferases (2.3) Aminoacyltransferases (2.3.2)
Sub-classes:MODULATION OF PROTEIN DEGRADATION
#2Compositions and Methods for Treating Disorders Associated with Cone Photoreceptor Cells
#3METHODS OF TREATING CANCERS
#4THERAPEUTIC AGENT FOR TREATING HIF-1alpha-MEDIATED DISEASES BY INHIBITING AREL1 AND RESTORING PHD2 ACTIVITY
#5HIGH-THROUGHPUT SCREENING METHODS TO IDENTIFY SMALL MOLECULE TARGETS
#6AGENTS FOR MODULATING EXPRESSION
#7POLYPEPTIDE SEQUENCING REAGENTS AND METHODS OF USE
#8METHOD FOR TREATING A PARKINSON'S DISEASE
#9IN SILICO METHOD OF IDENTIFYING ALLOSTERIC HECT E3-LIGASE INHIBITORS
#10FUSION PROTEINS COMPRISING AN E2 UBIQUITIN OR UBIQUITIN-LIKE CONJUGATING DOMAIN AND A TARGETING DOMAIN FOR SPECIFIC PROTEIN DEGRADATION
#11TARGET SUBSTRATE PROTEIN DEGRADATION PLATFORM
#12MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY
#13PROTEIN DEGRADATION SYSTEM, COMPONENTS, AND METHODS
#14METHODS FOR TREATING CELLULAR INFLAMMATION INDUCED BY AFB1
#15ASH1L degraders and methods of treatment therewith
#16POST-TRANSLATIONAL MODIFICATION CHIMERIC MOLECULE
#17NATURAL KILLER CELLS ENGINEERED TO REDUCE OR ELIMINATE CBL-B AND USES THEREOF
#18ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH
#19MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY
#20Molecules for organelle-specific protein delivery
#21COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION
#22ENHANCED HYT-INDUCED PROTEIN DEGRADATION USING LIPID NANOPARTICLE DELIVERY
#23WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES
#24MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME
#25DETECTION OF NOVEL DEGRADATION-RELATED INTERACTIONS
#26High-throughput screening methods to identify small molecule targets
#27Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)
#28ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS
#29MODULATION OF PROTEIN DEGRADATION
#30MODIFICATION OF HECT E3 UBIQUITIN LIGASE GENES TO IMPROVE YIELD TRAITS
#31High-Throughput Screening Methods to Identify Small Molecule Targets
#32UBE3A FOR THE TREATMENT OF ANGELMAN SYNDROME
#33SELECTIVE DEGRADATION OF PROTEINS
#34ASH1L inhibitors and methods of treatment therewith
#35RATIONAL THERAPEUTIC TARGETING OF ONCOGENIC IMMUNE SIGNALING STATES IN MYELOID MALIGNANCIES VIA THE UBIQUITIN CONJUGATING ENZYME UBE2N
#36ASH1L degraders and methods of treatment therewith
#37Breast and ovarian cancer vaccines
#38MINIMAL PEPTIDE FUSIONS FOR TARGETED INTRACELLULAR PROTEIN DEGRADATION
#39METHODS OF INHIBITING PROLIFERATIVE CELLS
#40SYSTEMS AND METHOD FOR SCREENING SMALL MOLECULES OF INTEREST
#41Molecules for organelle-specific protein delivery
#42Breast and ovarian cancer vaccines
#43PROTEIN LABELLING
#44ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM
#45GENE THERAPY FOR CNS DEGENERATION
#46Methods of treating cancers
#47OLIGONUCLEOTIDES FOR MODULATING PIAS4 EXPRESSION
#48INTRACELLULAR DELIVERY OF TARGET-SILENCING PROTEIN
#49BROAD-SPECTRUM PROTEOME EDITING WITH AN ENGINEERED BACTERIAL UBIQUITIN LIGASE MIMIC
#50Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
#51COMPOSITIONS AND METHODS FOR TREATING CANCER
#52ASH1L inhibitors and methods of treatment therewith
#53Breast and ovarian cancer vaccines
#54Use of Rad18 inhibitors in the treatment of tumors
#55MG53 mutants, methods of making the same, and uses thereof
#56ASH1L inhibitors and methods of treatment therewith
#57ASH1L degraders and methods of treatment therewith
#58Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
#59METHODS OF TREATING CANCER
#60Modified UBE3A gene for a gene therapy approach for angelman syndrome
#61USE OF RAD18 INHIBITORS IN THE TREATMENT OF TUMORS
#62Adenylation Enzyme Inhibitors
#63BARD1 isoforms in lung and colorectal cancer and use thereof
#64Breast and ovarian cancer vaccines
#65CYCLODIPEPTIDE SYNTHASES (CDSS) AND THEIR USE IN THE SYNTHESIS OF LINEAR DIPEPTIDES
#66Selective degradation of proteins